Lahore: Liven Pharma Limited has announced that a meeting of its Board of Directors is scheduled for March 14, 2025, at 2:00 PM. The meeting will be conducted virtually via Zoom, focusing on the review and consideration of the quarterly accounts for the period ending December 31, 2024. The company will also discuss the declaration of any entitlements during this session.

In compliance with the Pakistan Stock Exchange (PSX) regulations, Liven Pharma Limited has declared a closed period starting from March 7, 2025, and ending on March 14, 2025. During this timeframe, directors, the CEO, and executives are prohibited from dealing with the company’s shares, either directly or indirectly. This measure is in accordance with section 5.6.1(d) of the PSX regulations.

According to information available from the Pakistan Stock Exchange (PSX), stakeholders and TRE Certificate Holders are advised to take note of this closed period and the scheduled board meeting. The company's adherence to regulatory requirements underscores its commitment to transparent governance practices. Stakeholders are encouraged to stay informed about any developments that may arise from the board discussions, particularly any potential announcements regarding entitlements.